Why journals should not publish articles funded by the tobacco industryForAgainst
(Published 28 October 2000)
Cite this as: BMJ 2000;321:1074
That the tobacco industry is allowed a platform through scientific journals is a controversial issue. The Cancer Research Campaign already withholds research grants from academic departments closely linked with the tobacco industry; here it argues that respected journals should not publish articles funded by the industry. Such a notion is challenged by two editors, who prefer a policy of transparency and disclosure rather than prohibition.
- Jean King ([email protected]), director of education funding.
- The Cancer Research Campaign, London NW1 4JL
- a Western Journal of Medicine, San Francisco, CA 94105-1911, USA,
- b BMJ, London WC1H 9JR
The arguments for scientists refusing to accept funding from the tobacco industry and, by extension, journals refusing to accept publications arising from such funding, fall into three main categories (box 1).
Box 1: Arguments for refusing funding from the tobacco industry
Harm to health
The scale, range, and extent of the harm caused by tobacco far outweigh the effects of any other known product, legal or illegal
Distortion of scientific findings
Directly and indirectly the tobacco industry has systematically sought to undermine and misrepresent sound research on a massive scale, while itself funding studies and scientists of questionable credibility
Other disreputable activities
The tobacco industry's own documents show a uniquely discredited and disgraced sector that has sought to conceal evidence, recruit minors, and dupe the public and governments alike for many decades
Harm to health
The health risks associated with tobacco use have been detailed in many reports and were the basis of the justification for the Cancer Research Campaign's code of practice, which prohibits research groups in receipt of money from the tobacco industry from applying to it for funds (box 2).1–7
Distortion and “distraction” of scientific research
The tobacco industry has a long track record of seeking to cast doubt on good research, as shown in its own documents, now available on the internet owing to litigation cases in the United States. One tactic is to commission studies aimed at discrediting accepted findings: examples include studies that cast doubt on epidemiological findings, especially in relation to passive smoking, or which purport to identify other risk factors for …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial